RW

Reinhold W.

Chief Technology Officer

Reinhold Wimberger-Friedl, Chief Technology Officer (CTO) at Xyall



Contact Information:
  • Company: Xyall

  • Position: Chief Technology Officer (CTO)



Professional Background



Education:
  • Ph.D. in Mechanical Engineering

  • Master's Degree in Chemical Engineering


Key Expertise:
  • Specializes in automated tissue dissection

  • Known for integrating mechanical and chemical engineering principles in medical technology


Company Overview: Xyall



Industry: Medical Equipment
Headquarters: Eindhoven, North Brabant, The Netherlands
Company Size: 2-10 employees
Founded: 2018
Website: [Xyall](http://www.xyall.eu)

Core Focus:
  • Xyall provides automated tissue dissection solutions designed to enhance molecular pathology workflows.

  • Their technology, 'Tissector', digitizes and automates the tissue dissection process, aiding pathologists in obtaining reliable molecular diagnostic test results.


Notable Product:
  • Tissector TableTop System (TT)

  • Celebrating one year since launch

  • Successfully received in the market

  • Shipped globally


Recent Achievements:
  • Renewal of ISO 13485:2016 certification

  • Partnership with Labcorp and Covaris demonstrated enhanced efficiency and accuracy in tissue dissection


Reinhold Wimberger-Friedl's Contributions



  • Articles and Publications:

  • "Breakthrough in automated tissue dissection for molecular pathology lab"

  • This article, published in Clinical Laboratory International (October 2023), highlights the impact of Xyall's technology on sample selection and tissue dissection.


  • "Automating tissue dissection key to personalized medicine"

  • Featured in Medical Laboratory Observer (December 2023), this article discusses the critical role of automated tissue dissection in personalized medicine.


  • Professional Impact:

  • Reinhold has been a pioneering force behind Xyall's technological advancements, significantly impacting the efficiency and reliability of molecular pathology processes.

  • He has actively participated in industry discussions, presenting insights at prominent events such as SLAS2024.


Insights for Sales Background Research



  • Strategic Opportunities:

  • Xyall's strong focus on innovation in automated tissue dissection positions them as a key player in the molecular pathology market.

  • The successful adoption of the Tissector systems globally indicates robust market acceptance and potential for further expansion.

  • Reinhold Wimberger-Friedl's expertise and active presence in industry publications and conferences suggest a leadership team deeply engaged in thought leadership and continuous improvement of their technology.


  • Potential Collaborations and Partnerships:

  • Existing partnerships with Labcorp and Covaris highlight opportunities for collaborations that leverage Xyall's technology to further streamline pathology workflows.

  • Given Xyall's commitment to innovation, there may be opportunities for joint ventures or partnerships with companies focused on advanced diagnostic solutions and precision medicine.


This detailed profile provides a comprehensive overview of Reinhold Wimberger-Friedl's professional background, Xyall's core focus, and strategic insights valuable for engaging with Xyall in a collaborative or sales context.